Heron Therapeutics, Inc. /DE/ SEC filings HRTX
Heron Therapeutics, Inc. /DE/ has 1,000 filings in SEC EDGAR's recent list, going back to Jun 2, 2011. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| DEF 14A | Proxy statement | Sep 19, 2025 | Oct 13, 2025 |
| PRE 14A | Preliminary proxy statement | Sep 9, 2025 | Sep 9, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 12, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 13, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2024 | Jun 13, 2024 |
| DEF 14A | Proxy statement | May 1, 2023 | Jun 8, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2023 | Jun 8, 2023 |
| DEF 14A | Proxy statement | Apr 25, 2022 | May 24, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2022 | May 24, 2022 |
| DEFA14A | Additional proxy material | Apr 22, 2021 | — |
| DEF 14A | Proxy statement | Apr 22, 2021 | Jun 17, 2021 |
| DEFA14A | Additional proxy material | Apr 23, 2020 | — |
| DEF 14A | Proxy statement | Apr 23, 2020 | Jun 17, 2020 |
| DEFA14A | Additional proxy material | Apr 26, 2019 | — |
| DEF 14A | Proxy statement | Apr 26, 2019 | Jun 18, 2019 |
| DEFA14A | Additional proxy material | Apr 30, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 18, 2018 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2018 | Jun 18, 2018 |
| DEFA14A | Additional proxy material | Apr 26, 2017 | — |
| DEF 14A | Proxy statement | Apr 26, 2017 | Jun 12, 2017 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2017 | Jun 12, 2017 |
| DEFA14A | Additional proxy material | Apr 29, 2016 | — |
| DEF 14A | Proxy statement | Apr 29, 2016 | Jun 21, 2016 |
| DEF 14A | Proxy statement | Apr 28, 2015 | Jun 9, 2015 |
| DEF 14A | Proxy statement | Apr 24, 2014 | May 27, 2014 |
| DEF 14A | Proxy statement | Aug 26, 2013 | Sep 19, 2013 |
| PRE 14A | Preliminary proxy statement | Aug 13, 2013 | Sep 19, 2013 |
| DEF 14A | Proxy statement | May 9, 2013 | Jun 12, 2013 |
| DEF 14A | Proxy statement | Apr 24, 2012 | May 29, 2012 |
| DEF 14A | Proxy statement | Jun 3, 2011 | Jun 29, 2011 |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HRTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 818033
- Former names
- AP PHARMA INC /DE/ (until Jan 7, 2014); ADVANCED POLYMER SYSTEMS INC /DE/ (until Apr 6, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.